naproxen has been researched along with angiotensin ii in 3 studies
Studies (naproxen) | Trials (naproxen) | Recent Studies (post-2010) (naproxen) | Studies (angiotensin ii) | Trials (angiotensin ii) | Recent Studies (post-2010) (angiotensin ii) |
---|---|---|---|---|---|
4,551 | 1,057 | 1,429 | 38,152 | 1,089 | 7,413 |
Protein | Taxonomy | naproxen (IC50) | angiotensin ii (IC50) |
---|---|---|---|
Atrial natriuretic peptide receptor 3 | Homo sapiens (human) | 0.002 | |
Type-1A angiotensin II receptor | Rattus norvegicus (Norway rat) | 0.002 | |
Type-1B angiotensin II receptor | Rattus norvegicus (Norway rat) | 0.0018 | |
Type-1 angiotensin II receptor | Homo sapiens (human) | 0.0055 | |
Type-2 angiotensin II receptor | Rattus norvegicus (Norway rat) | 0.004 | |
Type-2 angiotensin II receptor | Homo sapiens (human) | 0.0011 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (66.67) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Foidart, JB; Mahieu, P | 1 |
Dunham, EW; Sakr, HM | 1 |
Adrahtas, A; Bertucci, MC; Cheung, RY; Krum, H; Ma, JY; Wang, BH | 1 |
3 other study(ies) available for naproxen and angiotensin ii
Article | Year |
---|---|
Glomerular mesangial cell contractility in vitro is controlled by an angiotensin-prostaglandin balance.
Topics: Angiotensin II; Animals; Arachidonic Acid; Arachidonic Acids; Cyclooxygenase Inhibitors; Dinoprostone; Fluorescent Antibody Technique; Glomerular Mesangium; Indomethacin; Lipoxygenase Inhibitors; Microscopy, Phase-Contrast; Naproxen; Prostaglandins; Prostaglandins E; Pyrazoles; Rats; Receptors, Angiotensin | 1986 |
Enhanced renal vasoconstriction in rats fed essential fatty acid-deficient diet.
Topics: Angiotensin II; Animals; Arachidonic Acid; Arachidonic Acids; Fatty Acids, Essential; Indomethacin; Kidney; Male; Naproxen; Norepinephrine; Rats; Rats, Inbred Strains; Regional Blood Flow; Vascular Resistance; Vasoconstriction | 1982 |
Celecoxib, but not rofecoxib or naproxen, attenuates cardiac hypertrophy and fibrosis induced in vitro by angiotensin and aldosterone.
Topics: Aldosterone; Angiotensin II; Animals; Animals, Newborn; Anti-Inflammatory Agents, Non-Steroidal; Cardiomegaly; Celecoxib; Collagen; Cyclooxygenase 2 Inhibitors; Female; Fibroblasts; Fibrosis; Heart; Hep G2 Cells; Hepatocytes; Humans; Lactones; Male; Myocardium; Myocytes, Cardiac; Naproxen; Pyrazoles; Rats; Renin-Angiotensin System; Sulfonamides; Sulfones; Vasoconstrictor Agents | 2010 |